This protocol addresses patients presenting with subarachnoid hemorrhage who develop elevated intracranial pressure or cerebral edema as a complication. The management approach is shaped specifically by this combination.
The protocol centres on intravenous therapy targeting intracranial pressure and cerebral edema, with a specific preference for how and when that therapy is delivered — guided by the patient's symptoms rather than a laboratory target.
Reduction of elevated intracranial pressure and cerebral edema in the setting of subarachnoid hemorrhage.
We suggest using symptom-based bolus dosing of hypertonic sodium solutions rather than sodium target-based dosing for the management of ICP or cerebral edema in patients with SAH (conditional recommendation, very low-quality evidence).
DOI: 10.1007/s12028-020-00959-7
View source ↗